High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Journal

TITLE

Nature Biotechnology

ISSUE

9

VOLUME

31

Related Patents

  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Use Of Cationic Lipids To Deliver Cas9
  • Regulatory Element Of An Arginine Decarboxylase Gene And Methods And Uses Thereof
  • Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Compositions Comprising Talens And Methods Of Treating Hiv
  • Genetic Correction Of Mutated Genes
  • Crispr Oligonucleotides And Gene Editing
  • Cas9 Variants And Uses Thereof
  • Cas Variants For Gene Editing
  • Modified Cascade Ribonucleoproteins And Uses Thereof
  • Compositions And Methods For Epigenome Editing
  • Crispr-Based Genome Modification And Regulation
  • Methods For Genomic Integration
  • Cas9 Proteins Including Ligand-Dependent Inteins
  • Editing Of Ccr5 Receptor Gene To Protect Against Hiv Infection
  • Dual Inhibition Of Ikk1 And Ikk2 For The Treatment Of Proliferative Diseases
  • Cas9-Dna Targeting Unit Chimeras
  • Crispr-Based Methods And Products For Increasing Frataxin Levels And Uses Thereof
  • Engineered Crispr-Cas9 Nucleases
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Crispr/Cas-Related Methods And Compositions For Treating Usher Syndrome And Retinitis Pigmentosa
  • Full Interrogation Of Nuclease Dsbs And Sequencing (Find-Seq)
  • Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
  • Compositions And Methods For Treating Cep290-Associated Disease
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Rna-Guided Gene Editing And Gene Regulation
  • Nuclease Profiling System
  • Compositions And Methods For Treating Cep290-Associated Disease
  • Genetically-Modified T Cells Comprising A Modified Intron In The T Cell Receptor Alpha Gene
  • Full Interrogation Of Nuclease Dsbs And Sequencing (Find-Seq)
  • Crispr Having Or Associated With Destabilization Domains
  • Aptazyme-Embedded Guide Rnas For Use With Crispr-Cas9 In Genome Editing And Transcriptional Activation
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Methods For Correcting Presenilin Point Mutations
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Engineered Crispr-Cas9 Nucleases
  • Adenosine Nucleobase Editors And Uses Thereof
  • Cas9 Proteins Including Ligand-Dependent Inteins
  • Aav Delivery Of Nucleobase Editors
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Engineered Crispr-Cas9 Nucleases
  • Methods For Identifying A Target Site Of A Cas9 Nuclease
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Methods And Kits For Isolation And Analysis Of A Chromatin Region
  • High Efficiency Base Editors Comprising Gam
  • Intracellular Genomic Transplant And Methods Of Therapy
  • Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Evaluation And Improvement Of Nuclease Cleavage Specificity
  • Nuclease-Mediated Targeting With Large Targeting Vectors
  • Rna-Guided Gene Editing And Gene Regulation
  • Mrna-Sensing Switchable Grnas
  • Methods And Compositions For Treatment Of A Genetic Condition
  • Cas9-Foki Fusion Proteins And Uses Thereof
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Methods For Nucleic Acid Editing
  • Methods And Compositions For Producing Double Allele Knock Outs
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Adenosine Nucleobase Editors And Uses Thereof
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Genome Editing Using Cas9 Nickases
  • Methods And Compositions For Treatment Of A Genetic Condition
  • Cas9-Recombinase Fusion Proteins And Uses Thereof
  • Novel Nucleic Acid Modifiers
  • Self-Limiting Viral Vectors Encoding Nucleases
  • Characterization And Inactivation Of Endogenous Retroviruses In Chinese Hamster Ovary Cells
  • Cas9 Proteins Including Ligand-Dependent Inteins
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Methods And Systems For Identifying Nucleotide-Guided Nuclease Off-Target Sites
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Preparation Of Libraries Of Protein Variants Expressed In Eukaryotic Cells And Use For Selecting Binding Molecules
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof
  • Tumor Infiltrating Lymphocytes And Methods Of Therapy
  • Methods And Compositions For Treatment Of A Genetic Condition
  • High Specificity Genome Editing Using Chemically Modified Guide Rnas
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Tumor Infiltrating Lymphocytes And Methods Of Therapy
  • Nucleobase Editors Comprising Nucleic Acid Programmable Dna Binding Proteins
  • Multiplex Guide Rnas
  • Rna-Guided Gene Editing System And Uses Thereof
  • Methods And Compositions For Treatment Of A Genetic Condition
  • Structure-Guided Chemical Modification Of Guide Rna And Its Applications
  • Switchable Grnas Comprising Aptamers
  • Animal Model And Method For Studying Gene-Gene Interactions
  • Comprehensive In Vitro Reporting Of Cleavage Events By Sequencing (Circle-Seq)
  • Methods For Cleaving A Target Dna Using A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein
  • Methods And Compositions For Cell Therapy
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Guide Rna With Chemical Modifications
  • Modified Cascade Ribonucleoproteins And Uses Thereof
  • Engineered Crispr-Cas9 Nucleases
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Gene Knockout Method
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Nucleobase Editors Comprising Nucleic Acid Programmable Dna Binding Proteins
  • Crispr-Based Genome Modification And Regulation
  • Switchable Cas9 Nucleases And Uses Thereof
  • Functional Genomics Using Crispr-Cas Systems, Compositions, Methods, Screens And Applications Thereof
  • Increasing Specificity For Rna-Guided Genome Editing
  • Intracellular Genomic Transplant And Methods Of Therapy
  • Programmable Cas9-Recombinase Fusion Proteins And Uses Thereof
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Evaluation And Improvement Of Nuclease Cleavage Specificity
  • Gene Editing Reagents With Reduced Toxicity
  • Nucleic Acid Assemblies For Use In Targeted Delivery
  • Dna-Pkcs Inhibitors For Increasing Genome Editing Efficiency
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Engineered Meganucleases With Recognition Sequences Found In The Human T Cell Receptor Alpha Constant Region Gene
  • Methods And Kits For Isolation And Analysis Of A Chromatin Region
  • Methods And Kits For Isolation And Analysis Of A Chromatin Region
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Increasing Specificity For Rna-Guided Genome Editing
  • Delivery Of Negatively Charged Proteins Using Cationic Lipids
  • Cas Variants For Gene Editing
  • Compounds For Increasing Genome Editing Efficiency
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Modified Cells And Methods Of Therapy
  • Genetic Correction Of Mutated Genes
  • Compositions And Methods For The Induction And Tuning Of Gene Expression
  • Nucleobase Editors And Uses Thereof
  • Modified Cells And Methods Of Therapy
  • Methods And Compositions For Producing Double Allele Knock Outs
  • Lentiviral Nanoparticles
  • Engineered Crispr-Cas9 Nucleases
  • Comprehensive In Vitro Reporting Of Cleavage Events By Sequencing (Circle-Seq)
  • Compositions, Systems And Methods For Cell Therapy
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Tumor Infiltrating Lymphocytes And Methods Of Therapy
  • Switchable Cas9 Nucleases And Uses Thereof
  • Compositions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Pluripotent Stem Cell-Derived 3d Retinal Tissue And Uses Thereof
  • Fusions Of Cas9 Domains And Nucleic Acid-Editing Domains
  • Extended Dna-Sensing Grnas
  • Compounds For Increasing Genome Editing Efficiency
  • Crispr-Related Methods And Compositions With Governing Grnas
  • Methods For Genomic Integration
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Type Vi Crispr Orthologs And Systems
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Immunosuppressant-Resistant T-Cells For Adoptive Immunotherapy
  • Crispr Oligonucleotides And Gene Editing
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Nucleic Acids Encoding Engineered Meganucleases With Recognition Sequences Found In The Human T Cell Receptor Alpha Constant Region Gene
  • Methods And Kits For Isolation And Analysis Of A Chromatin Region
  • Inhibitors Of Rna-Guided Nuclease Target Binding And Uses Thereof
  • Delivery System For Functional Nucleases
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Modified Cascade Ribonucleoproteins And Uses Thereof
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Chemical-Inducible Genome Engineering Technology
  • Delivery System For Functional Nucleases
  • Evaluation Of Cas9 Molecule/Guide Rna Molecule Complexes
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Cas9-Cas9 Fusion Proteins
  • Site-Specific Dna Break-Induced Genome Editing Using Engineered Nucleases
  • Engineered Crispr-Cas9 Nucleases
  • Delivery Of Negatively Charged Proteins Using Cationic Lipids
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Engineered Crispr-Cas9 Nucleases
  • Adeno-Associated Viral Vectors For Gene Therapy
  • Cas9 Variants And Uses Thereof
  • Methods For Increasing Cas9-Mediated Engineering Efficiency
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Using Programmable Dna Binding Proteins To Enhance Targeted Genome Modification
  • Compostions And Methods Of Nucleic Acid-Targeting Nucleic Acids
  • Compounds For Increasing Genome Editing Efficiency
  • Methods For Identifying A Target Site Of A Cas9 Nuclease
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Methods For Genomic Integration
  • Crispr/Cas-Related Methods And Compositions For Treating Sickle Cell Disease
  • Dual Inhibition Of Ikk1 And Ikk2 For The Treatment Of Proliferative Diseases
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Increasing Specificity For Rna-Guided Genome Editing
  • Crispr/Cas-Related Methods And Compositions For Treating Leber's Congenital Amaurosis 10 (Lca10)
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Methods For Increasing Cas9-Mediated Engineering Efficiency
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Cytidine Deaminase Variants For Base Editing
  • Method For The Monitoring Of Modified Nucleases Induced-Gene Editing Events By Molecular Combing
  • Nucleobase Editors And Uses Thereof
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Modified Cascade Ribonucleoproteins And Uses Thereof
  • Novel Nucleic Acid Modifier
  • Generation And Correction Of A Humanized Mouse Model With A Deletion Of Dystrophin Exon 44
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nbt.2623

    DOI

    http://dx.doi.org/10.1038/nbt.2623

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1009511624

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/23792628


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fu", 
            "givenName": "Yanfang", 
            "id": "sg:person.0745031367.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745031367.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.32224.35", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Foden", 
            "givenName": "Jennifer A", 
            "id": "sg:person.01140133375.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140133375.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.32224.35", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Khayter", 
            "givenName": "Cyd", 
            "id": "sg:person.0650177731.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650177731.59"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maeder", 
            "givenName": "Morgan L", 
            "id": "sg:person.01144713655.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144713655.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Reyon", 
            "givenName": "Deepak", 
            "id": "sg:person.0760565231.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760565231.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA", 
                "Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Joung", 
            "givenName": "J Keith", 
            "id": "sg:person.0667170477.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667170477.75"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA", 
                "Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sander", 
            "givenName": "Jeffry D", 
            "id": "sg:person.01075013631.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075013631.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/cr.2013.46", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038811201", 
              "https://doi.org/10.1038/cr.2013.46"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024988605", 
              "https://doi.org/10.1038/nbt.2501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1410", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048577624", 
              "https://doi.org/10.1038/nbt1410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2170", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040026920", 
              "https://doi.org/10.1038/nbt.2170"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1927", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047844983", 
              "https://doi.org/10.1038/nbt.1927"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1948", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033698278", 
              "https://doi.org/10.1038/nbt.1948"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.1670", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043918422", 
              "https://doi.org/10.1038/nmeth.1670"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2507", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041881936", 
              "https://doi.org/10.1038/nbt.2507"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2508", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019888616", 
              "https://doi.org/10.1038/nbt.2508"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature10886", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053669571", 
              "https://doi.org/10.1038/nature10886"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-06-23", 
        "datePublishedReg": "2013-06-23", 
        "description": "CAS9 nucleases, a new tool for genome editing, show significant offtarget activity.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nbt.2623", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2440618", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2520480", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2354980", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1115214", 
            "issn": [
              "1087-0156", 
              "1546-1696"
            ], 
            "name": "Nature Biotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "31"
          }
        ], 
        "keywords": [
          "off-target mutagenesis", 
          "CRISPR-Cas nucleases", 
          "Cas9 nuclease", 
          "genome editing", 
          "human cells", 
          "nuclease", 
          "mutagenesis", 
          "new tool", 
          "editing", 
          "cells", 
          "activity", 
          "tool"
        ], 
        "name": "High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells", 
        "pagination": "822-826", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1009511624"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nbt.2623"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "23792628"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nbt.2623", 
          "https://app.dimensions.ai/details/publication/pub.1009511624"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-08-04T17:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_589.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nbt.2623"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nbt.2623'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nbt.2623'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nbt.2623'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nbt.2623'


     

    This table displays all metadata directly associated to this object as RDF triples.

    163 TRIPLES      20 PREDICATES      45 URIs      29 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nbt.2623 schema:author N54cfc0962d4b423ba6aa04ebf8b16ec7
    2 schema:citation sg:pub.10.1038/cr.2013.46
    3 sg:pub.10.1038/nature10886
    4 sg:pub.10.1038/nbt.1927
    5 sg:pub.10.1038/nbt.1948
    6 sg:pub.10.1038/nbt.2170
    7 sg:pub.10.1038/nbt.2501
    8 sg:pub.10.1038/nbt.2507
    9 sg:pub.10.1038/nbt.2508
    10 sg:pub.10.1038/nbt1410
    11 sg:pub.10.1038/nmeth.1670
    12 schema:datePublished 2013-06-23
    13 schema:datePublishedReg 2013-06-23
    14 schema:description CAS9 nucleases, a new tool for genome editing, show significant offtarget activity.
    15 schema:genre article
    16 schema:isAccessibleForFree true
    17 schema:isPartOf N7ab72dd271c84fb38f23c74c67f736ab
    18 Na5f171b9ed7e426888ea51599a2cf02c
    19 sg:journal.1115214
    20 schema:keywords CRISPR-Cas nucleases
    21 Cas9 nuclease
    22 activity
    23 cells
    24 editing
    25 genome editing
    26 human cells
    27 mutagenesis
    28 new tool
    29 nuclease
    30 off-target mutagenesis
    31 tool
    32 schema:name High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
    33 schema:pagination 822-826
    34 schema:productId N7bf2652c70ba4f5a81b35130cf32d51e
    35 N859ec7b951344b3999510edeb246b09c
    36 Nfab1d11a50e54ebe8597d4db2bd65ddd
    37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009511624
    38 https://doi.org/10.1038/nbt.2623
    39 schema:sdDatePublished 2022-08-04T17:00
    40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    41 schema:sdPublisher N2cbaf8433f4c41f38e0e428d4d8165e2
    42 schema:url https://doi.org/10.1038/nbt.2623
    43 sgo:license sg:explorer/license/
    44 sgo:sdDataset articles
    45 rdf:type schema:ScholarlyArticle
    46 N245e3857668f477aad81f5a1e2dbf13b rdf:first sg:person.01144713655.34
    47 rdf:rest Ndcd94182d64e4b86a9524b9578b0d48a
    48 N2cbaf8433f4c41f38e0e428d4d8165e2 schema:name Springer Nature - SN SciGraph project
    49 rdf:type schema:Organization
    50 N467af6ee7c5e4e94bf0e35a55ea6c923 rdf:first sg:person.01075013631.38
    51 rdf:rest rdf:nil
    52 N54cfc0962d4b423ba6aa04ebf8b16ec7 rdf:first sg:person.0745031367.43
    53 rdf:rest Nefc4114f6cef432fafdde00ed048acee
    54 N7ab72dd271c84fb38f23c74c67f736ab schema:volumeNumber 31
    55 rdf:type schema:PublicationVolume
    56 N7bf2652c70ba4f5a81b35130cf32d51e schema:name pubmed_id
    57 schema:value 23792628
    58 rdf:type schema:PropertyValue
    59 N859ec7b951344b3999510edeb246b09c schema:name dimensions_id
    60 schema:value pub.1009511624
    61 rdf:type schema:PropertyValue
    62 Na5f171b9ed7e426888ea51599a2cf02c schema:issueNumber 9
    63 rdf:type schema:PublicationIssue
    64 Nd3dfd77350094d6398e8fc25ac852fc7 rdf:first sg:person.0667170477.75
    65 rdf:rest N467af6ee7c5e4e94bf0e35a55ea6c923
    66 Ndcd94182d64e4b86a9524b9578b0d48a rdf:first sg:person.0760565231.98
    67 rdf:rest Nd3dfd77350094d6398e8fc25ac852fc7
    68 Nefc4114f6cef432fafdde00ed048acee rdf:first sg:person.01140133375.19
    69 rdf:rest Nf48d7e6b84dc4a4cb8a575bac4eb6a98
    70 Nf48d7e6b84dc4a4cb8a575bac4eb6a98 rdf:first sg:person.0650177731.59
    71 rdf:rest N245e3857668f477aad81f5a1e2dbf13b
    72 Nfab1d11a50e54ebe8597d4db2bd65ddd schema:name doi
    73 schema:value 10.1038/nbt.2623
    74 rdf:type schema:PropertyValue
    75 sg:grant.2354980 http://pending.schema.org/fundedItem sg:pub.10.1038/nbt.2623
    76 rdf:type schema:MonetaryGrant
    77 sg:grant.2440618 http://pending.schema.org/fundedItem sg:pub.10.1038/nbt.2623
    78 rdf:type schema:MonetaryGrant
    79 sg:grant.2520480 http://pending.schema.org/fundedItem sg:pub.10.1038/nbt.2623
    80 rdf:type schema:MonetaryGrant
    81 sg:journal.1115214 schema:issn 1087-0156
    82 1546-1696
    83 schema:name Nature Biotechnology
    84 schema:publisher Springer Nature
    85 rdf:type schema:Periodical
    86 sg:person.01075013631.38 schema:affiliation grid-institutes:grid.38142.3c
    87 schema:familyName Sander
    88 schema:givenName Jeffry D
    89 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075013631.38
    90 rdf:type schema:Person
    91 sg:person.01140133375.19 schema:affiliation grid-institutes:grid.32224.35
    92 schema:familyName Foden
    93 schema:givenName Jennifer A
    94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140133375.19
    95 rdf:type schema:Person
    96 sg:person.01144713655.34 schema:affiliation grid-institutes:grid.38142.3c
    97 schema:familyName Maeder
    98 schema:givenName Morgan L
    99 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144713655.34
    100 rdf:type schema:Person
    101 sg:person.0650177731.59 schema:affiliation grid-institutes:grid.32224.35
    102 schema:familyName Khayter
    103 schema:givenName Cyd
    104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650177731.59
    105 rdf:type schema:Person
    106 sg:person.0667170477.75 schema:affiliation grid-institutes:grid.38142.3c
    107 schema:familyName Joung
    108 schema:givenName J Keith
    109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667170477.75
    110 rdf:type schema:Person
    111 sg:person.0745031367.43 schema:affiliation grid-institutes:grid.38142.3c
    112 schema:familyName Fu
    113 schema:givenName Yanfang
    114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0745031367.43
    115 rdf:type schema:Person
    116 sg:person.0760565231.98 schema:affiliation grid-institutes:grid.38142.3c
    117 schema:familyName Reyon
    118 schema:givenName Deepak
    119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760565231.98
    120 rdf:type schema:Person
    121 sg:pub.10.1038/cr.2013.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038811201
    122 https://doi.org/10.1038/cr.2013.46
    123 rdf:type schema:CreativeWork
    124 sg:pub.10.1038/nature10886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053669571
    125 https://doi.org/10.1038/nature10886
    126 rdf:type schema:CreativeWork
    127 sg:pub.10.1038/nbt.1927 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047844983
    128 https://doi.org/10.1038/nbt.1927
    129 rdf:type schema:CreativeWork
    130 sg:pub.10.1038/nbt.1948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033698278
    131 https://doi.org/10.1038/nbt.1948
    132 rdf:type schema:CreativeWork
    133 sg:pub.10.1038/nbt.2170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040026920
    134 https://doi.org/10.1038/nbt.2170
    135 rdf:type schema:CreativeWork
    136 sg:pub.10.1038/nbt.2501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024988605
    137 https://doi.org/10.1038/nbt.2501
    138 rdf:type schema:CreativeWork
    139 sg:pub.10.1038/nbt.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881936
    140 https://doi.org/10.1038/nbt.2507
    141 rdf:type schema:CreativeWork
    142 sg:pub.10.1038/nbt.2508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019888616
    143 https://doi.org/10.1038/nbt.2508
    144 rdf:type schema:CreativeWork
    145 sg:pub.10.1038/nbt1410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048577624
    146 https://doi.org/10.1038/nbt1410
    147 rdf:type schema:CreativeWork
    148 sg:pub.10.1038/nmeth.1670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043918422
    149 https://doi.org/10.1038/nmeth.1670
    150 rdf:type schema:CreativeWork
    151 grid-institutes:grid.32224.35 schema:alternateName Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    152 schema:name Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    153 Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    154 Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    155 rdf:type schema:Organization
    156 grid-institutes:grid.38142.3c schema:alternateName Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
    157 Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA
    158 schema:name Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    159 Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    160 Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
    161 Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    162 Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA
    163 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...